Business
Frazier Financial Advisors Cuts JPMorgan Chase Holdings by 1%
Frazier Financial Advisors LLC has reduced its stake in JPMorgan Chase & Co. (NYSE:JPM) by 1.0% during the second quarter of 2023. According to the firm’s latest Form 13F filing with the U.S. Securities and Exchange Commission (SEC), Frazier now holds 6,414 shares of the financial services giant after selling 68 shares in the period. This adjustment brings JPMorgan Chase’s weight in Frazier’s portfolio to approximately 1.3%, ranking it as the firm’s 15th largest investment.
As of the most recent SEC filing, Frazier Financial Advisors’ holdings in JPMorgan Chase were valued at about $1.86 million. Other significant investors also made adjustments to their positions in the company during the same quarter. For instance, IFC Advisors LLC increased its stake in JPMorgan Chase by 4.4%, owning a total of 36,381 shares valued at $10.55 million after acquiring an additional 1,525 shares.
Founders Grove Wealth Partners LLC also raised its stake by 12.9%, bringing its total to 2,711 shares worth approximately $786,000. Meanwhile, Morningstar Investment Management LLC established a new position valued at around $811,000. Other firms such as Performance Wealth Partners LLC and Naviter Wealth LLC also expanded their holdings, with increases of 2.0% and 2.4%, respectively.
Hedge funds and institutional investors collectively own 71.55% of JPMorgan Chase’s stock, indicating strong institutional confidence in the firm’s performance.
In a separate development, Director Linda Bammann sold 9,500 shares of JPMorgan Chase stock on September 2, 2023, at an average price of $297.94, resulting in a total transaction value of approximately $2.83 million. Following this sale, she retains a total of 82,207 shares, valued at about $24.49 million.
JPMorgan Chase’s Financial Performance and Outlook
JPMorgan Chase opened trading at $300.27 on Friday. The company has demonstrated robust financial metrics, including a current ratio of 0.86, a quick ratio of 0.88, and a debt-to-equity ratio of 1.26. With a market capitalization of $825.66 billion, the firm boasts a price-to-earnings ratio of 14.87 and a PEG ratio of 1.77. Over the past year, JPMorgan Chase’s stock has fluctuated, hitting a low of $202.16 and a high of $318.01.
On October 14, 2023, the company reported its earnings for the third quarter, revealing earnings per share (EPS) of $5.07, surpassing analysts’ expectations of $4.83 by $0.24. The revenue for the quarter reached $46.43 billion, exceeding analyst forecasts of $44.42 billion. Year-over-year, JPMorgan Chase’s quarterly revenue has increased by 8.8%, with a return on equity of 17.18% and a net margin of 20.90%.
Dividend Announcement and Future Projections
In a positive move for shareholders, JPMorgan Chase has announced a quarterly dividend of $1.50 per share, payable on October 31, 2023. Investors of record on October 6, 2023, will qualify for this dividend, which is an increase from the previous quarter’s dividend of $1.40. This represents an annualized dividend of $6.00 and a yield of 2.0%. The company’s current dividend payout ratio stands at 29.72%.
JPMorgan Chase & Co. operates as a financial holding company, providing a wide range of services including investment banking, consumer banking, and asset management. The firm is structured into several segments: Consumer and Community Banking, Commercial and Investment Banking, Asset and Wealth Management, and Corporate.
For those interested in following institutional investments in JPMorgan Chase, recent filings and insider trades can be viewed on the SEC website, offering transparency in the company’s financial dealings and market position.
-
Science2 months agoInventor Achieves Breakthrough with 2 Billion FPS Laser Video
-
Health2 months agoCommunity Unites for 7th Annual Into the Light Walk for Mental Health
-
Top Stories2 months agoCharlie Sheen’s New Romance: ‘Glowing’ with Younger Partner
-
Entertainment2 months agoDua Lipa Aces GCSE Spanish, Sparks Super Bowl Buzz with Fans
-
Health2 months agoCurium Group, PeptiDream, and PDRadiopharma Launch Key Cancer Trial
-
Top Stories2 months agoFormer Mozilla CMO Launches AI-Driven Cannabis Cocktail Brand Fast
-
Entertainment2 months agoMother Fights to Reunite with Children After Kidnapping in New Drama
-
World2 months agoIsrael Reopens Rafah Crossing After Hostage Remains Returned
-
World2 months agoR&B Icon D’Angelo Dies at 51, Leaving Lasting Legacy
-
Business2 months agoTyler Technologies Set to Reveal Q3 Earnings on October 22
-
Health2 months agoYouTube Launches New Mental Health Tools for Teen Users
-
Health2 months agoNorth Carolina’s Biotech Boom: Billions in New Investments
